US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

32.66

+0.40021.24%

Volume:9K

Turnover:282.96K

Market Cap:53.04M

PE:- -

High:32.78

Open:32.73

Low:32.55

Close:32.26

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.96

T/O Rate:0.53%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.67% on Aug 19: Facts Behind the Movement

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live

Insider Move At Lifestance Health Group Sparks Investor Attention

Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says

MT Newswires Live

Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says

MT Newswires Live

Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says

MT Newswires Live

Argenx Se : Morgan Stanley Raises Target Price to $1230.00 from $1200.00

THOMSON REUTERS

Argenx price target raised to $1,150 from $1,050 at Wedbush

10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance

Simply Wall St.

Argenx Se (ARGX) Receives a Buy from Citi

Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback

Simply Wall St.

Argenx Se : TD Cowen Raises Target Price to $1353 from $1146

THOMSON REUTERS

Argenx Se : Truist Securities Raises Target Price to $1095 from $1030

THOMSON REUTERS

Steris PLC Stock Underperforms Monday When Compared to Competitors

ADRs Close Higher; Argenx SE Climbs 16%

10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares

William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path

Argenx Stock Heads for Record After Blockbuster Drug Delivers Another Win

argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement

Argenx Price Target Raised to $1215.00/Share from $1075.00 by Piper Sandler

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FMED/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":32.6632,"timestamp":1787688000000,"preClose":32.263,"halted":0,"volume":8657,"delay":0,"changeRate":0.012404302141772471,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Pre-Mkt","change":0.4002,"latestTime":"08-26 06:41:45 EDT","open":32.73,"high":32.78,"low":32.55,"amount":282962.676029,"amplitude":0.007129,"askPrice":51.93,"askSize":100,"bidPrice":13.14,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":32.6632,"sharesOutstanding":2323806,"nav":32.280091,"aum":52416605.446346,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.61,"preClose":32.6632,"latestTime":"19:30 EDT","volume":9,"amount":293.9688,"timestamp":1787700602777,"change":-0.0532,"changeRate":-0.001629,"amplitude":0},"volumeRatio":0.9634518293500154,"impliedVol":0.0806,"impliedVolPercentile":0.2335},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9634518293500154,"shares":1623806,"dividePrice":0,"high":32.78,"amplitude":0.007129,"preClose":32.263,"low":32.55,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":32.6632,"eps":0,"divideRate":0,"volume":8657,"delay":0,"ttmEps":0,"open":32.73,"prevYearClose":27.05,"prevWeekClose":32.5289,"prevMonthClose":27.9952,"prevQuarterClose":28.525,"fiveDayClose":30.7396,"twentyDayClose":28.6618,"sixtyDayClose":25.165},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660427589","title":"Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.67% on Aug 19: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427589","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427589?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:15","pubTimestamp":1787159744,"startTime":"0","endTime":"0","summary":"• Thermo Fisher raised its full-year outlook following strong second-quarter financial results.\n• The company sold its microbiology business to Astorg for over one billion dollars.\n• Institutional managers and hedge funds recently built fresh positions in the company.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118659-market-movers-tmo-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0342679015.USD","BK4533","GB00BDT5M118.USD","IE00B1BXHZ80.USD","LU1720051108.HKD","LU1670628061.USD","LU1988902786.USD","IE00BKPKM429.USD","BK4566","BK4585","LU2764263203.CNY","LU0640476718.USD","LU0011850046.USD","LU2764262908.HKD","LU1815333072.USD","LU0432979614.USD","LU2125910179.SGD","LU0061474960.USD","BK4121","LU1023059063.AUD","LU1712237335.SGD","LU2125909759.SGD","LU2092937221.SGD","LU1548497426.USD","LU0310800379.SGD","LU1061106388.HKD","LU1803068623.USD","BK4588","IE0034235188.USD","LU1720051017.SGD","LU0234572021.USD","IE0009355771.USD","LU1989771016.USD","LU0882574055.USD","LU0528227936.USD","LU1923621640.USD","LU2433249047.HKD","IE00BQXX3F31.USD","LU1854104046.USD","LU0029864427.USD","LU1267930573.SGD","LU0070302665.USD","LU0557290698.USD","LU1291159041.SGD","LU2357305700.SGD","LU1280957306.USD","LU1791710582.SGD","IE00BQXX3C00.GBP","LU1791710400.SGD","GNMX","LU1854103824.USD","LU1923622614.USD","LU0708994859.HKD","LU0345770308.USD","LU0823416689.USD","LU1633808545.USD","LU1153585028.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU2360108059.USD","LU2764263039.SGD","LU2125909593.SGD","LU2264538146.SGD","LU2063271972.USD","BK4535","LU1623119135.USD","LU2211815571.USD","LU0320765489.SGD","IE00B19Z8W00.USD","BK4548","IE0002141913.USD","LU2543165471.USD","LU0122379950.USD","LU1923622291.USD","LU0266013472.USD","LU1670627923.USD","LU0114720955.EUR","LU1064131342.USD","IE00BJT1NW94.SGD","LU1983299246.USD","LU2089984988.USD","BK4534","LU2211814178.USD","LU2112291526.USD","LU2041044095.USD","LU2125910336.SGD","BK4581","IE00B2B36J28.USD","LU0096362180.USD","IE00B19Z9505.USD","LU2125909247.SGD","IE00B19Z8X17.USD","HRTS","LU0345770993.USD","FMED","LU2468319806.SGD","LU0316494557.USD","LU2720916845.USD","TMED","LU0208291251.USD","LU0957791311.USD","LU0128525929.USD","IE00BQXX3D17.EUR","LU2298321311.HKD","LU2125909916.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","TMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421716","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421716","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421716?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:18","pubTimestamp":1787152727,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.68% to 1,973.64 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm BioNTech  and biopharmaceutical company Grifols , which advanced 24% and 5.6% respectively. They were followed by semiconductor company Sequans Communications  and biopharmaceutical company argenx , which rose 3.3% and 3% respectively.The decliners from continental Europe were led by internet browser company Opera  and biotech firm Evaxion , which fell 7.9% and 6% respectively. They were followed by accommodations booking site Trivago  and telecommunications company Nokia , which were down 4.3% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and mining company BHP Group , which increased 9.2% and 4.5% respectively. They were followed by software firm Endava  and biopharmaceutical company Bicycle Therapeutics , w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AUTL","BK4548","GRFS","BK4585","SNN","NOK","EVAX","TBXU","BK4141","FMED","NVIB","BNTX","DAVA","BK4547","IE00B4R5TH58.HKD","OPRA","IE00BJJMRZ35.SGD","IBB","ARGX","IE00BMPRXN33.USD","LU0889565916.HKD","SLX","LU0006061336.USD","LU0109394709.USD","PUK","DAVA.AU","LU0823416689.USD","BK4588","IEUR","BDRX","BK4117","TRIB","LU1983260115.SGD","LNOK","IE00BJT1NW94.SGD","BHP","BHP.AU","AFG","IE0009355771.USD","BCYC","LFGY","LU0300736062.USD","LU2324357040.USD","COAL","IE00B2B36J28.USD","TRVG","EPV","LU0648005311.SGD","XBIX","SQNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660249416","title":"Insider Move At Lifestance Health Group Sparks Investor Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2660249416","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660249416?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:09","pubTimestamp":1787105395,"startTime":"0","endTime":"0","summary":"New insider activity at Lifestance Health Group ( ($LFST) ) has taken place on August 18, 2026. Director Teresa DeLuca of Lifestance Health Group h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-at-lifestance-health-group-sparks-investor-attention-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-at-lifestance-health-group-sparks-investor-attention-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4196","LFST","FMED","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495742","title":"Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495742","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495742?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:35","pubTimestamp":1787067344,"startTime":"0","endTime":"0","summary":"Argenx's  phase 3 data on Vyvgart reduce the uncertainty around its potential $1.5 billion to $2 billion autoimmune myositis opportunity, Oppenheimer said.The phase 3 study of Vyvgart achieved its primary endpoint for the combined dermatomyositis and immune-mediated necrotizing myopathy, or IMNM, population, the investment firm said in a Monday note, noting IMNM as the therapy's \"most derisked\" path to approval.In the IMNM subgroup, Vyvgart-treated patients showed a 14.8-point greater improvement in mean Total Improvement Score versus placebo at week 52, a statistically significant result with a p-value of 0.0048, Oppenheimer added.The results are a testament to the company's pipeline-in-a-product strategy, bringing it closer to entering rheumatology as a second therapeutic category, according to the noteOppenheimer raised its price target on argenx to $1,100 from $1,037, while keeping its outperform outlook.Shares of Argenx were up 1.1% in Tuesday trading.Price: 998.83, Change: +10.99","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","BK4585","IE0002141913.USD","FMED","TBXU","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IBB","ARGX","LU0889565916.HKD","LU0109394709.USD","BK4139","LU0823416689.USD","IE0034235188.USD","BK4588","LU1983260115.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2324357040.USD","OPY","IE00B2B36J28.USD","BK4127","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495503","title":"Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495503","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495503?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:06","pubTimestamp":1787065592,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) Vyvgart Hytrulo is likely to get approval from the US Food and Drug Administration for adults with immune-mediated necrotizing myopathy and dermatomyositis, RBC Capital Markets analyst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","ARGX","BK4585","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","LABU","LU1983260115.SGD","IE0034235188.USD","IE0002141913.USD","BK4588","LU0320765992.SGD","LU0823416689.USD","LU0889565916.HKD","TBXU","LU2324357040.USD","LU0109394709.USD","IE00B2B36J28.USD","IBB","FMED","BK4505","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660070493","title":"Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660070493","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660070493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:54","pubTimestamp":1787064888,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) latest myositis data strengthened the outlook for efgartigimod, particularly in immune-mediated necrotizing myopathy, resulting in higher probability-of-success assumptions, Morgan Sta","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4563","IE00B2B36J28.USD","TBXU","FMED","IE00B4R5TH58.HKD","LU0823416689.USD","ARGX","LU2324357040.USD","IMNM","LU0889565916.HKD","BK4505","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588","LU1983260115.SGD","LU0109394709.USD","BK4139","IBB","IE00BFTCPJ56.SGD","IE0034235188.USD","IE0002141913.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660646056","title":"Argenx Se : Morgan Stanley Raises Target Price to $1230.00 from $1200.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2660646056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660646056?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:12","pubTimestamp":1787058744,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nAZN4TEZHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARGX","IE00BJT1NW94.SGD","FMED","IE00B4R5TH58.HKD","IE0002141913.USD","LU0109394709.USD","TBXU","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4505","IE00BJJMRZ35.SGD","BK4139","LU0823416689.USD","IE0009355771.USD","IE0034235188.USD","LU2324357040.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","BK4588","BK4585","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462876","title":"Argenx price target raised to $1,150 from $1,050 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462876?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:50","pubTimestamp":1787053809,"startTime":"0","endTime":"0","summary":"Wedbush raised the firm’s price target on Argenx (ARGX) to $1,150 from $1,050 and keeps an Outperform rating on the shares. The firm notes the comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1150-from-1050-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1150-from-1050-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","LU0320765992.SGD","ARGX","IE0002141913.USD","IE0034235188.USD","IE00BJJMRZ35.SGD","IBB","LU0823416689.USD","BK4585","FMED","BK4139","LU2324357040.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4505","LU1983260115.SGD","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469194","title":"10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469194","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469194?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:25","pubTimestamp":1787045146,"startTime":"0","endTime":"0","summary":"10x Genomics stock has delivered a very strong 330.8% return over the past year, yet the current valuation checks lean expensive rather than pointing to an obvious bargain.\n\nThe 330.8% gain over 12 months highlights how quickly expectations have shifted for 10x Genomics, which raises the bar for what the business now needs to deliver.\nStronger interest in the Atera spatial biology platform and related partnerships can support higher revenue expectations, while any slowdown in that demand or...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-fully-priced-as-atera-demand-li","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-fully-priced-as-atera-demand-li","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","TXG","FMED","LU1861558580.USD","BK4548","LU1861559042.SGD","LU0963586101.USD","ARKG","BK4121","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660457633","title":"Argenx Se (ARGX) Receives a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660457633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660457633?lang=en_us&edition=fundamental","pubTime":"2026-08-18 14:55","pubTimestamp":1787036118,"startTime":"0","endTime":"0","summary":"In a report released today, Samantha Semenkow from Citi maintained a Buy rating on Argenx Se, with a price target of $1,301.00. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","LU1983260115.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","BK4588","ARGX","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD","TBXU","IE00BJJMRZ35.SGD","IBB","LU0320765992.SGD","IE00B2B36J28.USD","BK4585","IE0009355771.USD","IE0034235188.USD","FMED","LU0823416689.USD","LU2324357040.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660452322","title":"Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2660452322","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660452322?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:21","pubTimestamp":1787030492,"startTime":"0","endTime":"0","summary":"In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$97.19 million share repurchase program under its February 2026 authorization while also announcing a new up to US$100 million buyback.\nThe company also raised its full-year 2026 revenue outlook to a range of US$1.69 billion to US$1.73 billion, signaling management’s confidence alongside this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AIPO","BK4535","FMED","BK4196","BK4539","LFST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660451398","title":"Argenx Se : TD Cowen Raises Target Price to $1353 from $1146","url":"https://stock-news.laohu8.com/highlight/detail?id=2660451398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660451398?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:16","pubTimestamp":1787026573,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","IE00B4R5TH58.HKD","LU1983260115.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0889565916.HKD","IE0034235188.USD","LU0823416689.USD","BK4588","IE0002141913.USD","BK4139","ARGX","IE00BFTCPJ56.SGD","TBXU","IE0009355771.USD","IBB","LU0320765992.SGD","LU2324357040.USD","IE00BJT1NW94.SGD","FMED","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456165","title":"Argenx Se : Truist Securities Raises Target Price to $1095 from $1030","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456165?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:39","pubTimestamp":1787020796,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","LU0320765992.SGD","ARGX","IE0002141913.USD","IE0034235188.USD","IE00BJJMRZ35.SGD","IBB","LU0823416689.USD","BK4585","FMED","BK4139","LU2324357040.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4505","LU1983260115.SGD","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660243207","title":"Steris PLC Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660243207","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660243207?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:07","pubTimestamp":1787000820,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  slid 1.51% to $229.75 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.52% to 7,745.06 and Dow Jones Industrial Average  falling 0.51% to 53,459.78.This was the stock's fifth consecutive day of losses.Steris PLC closed 14.73% below its 52-week high of $269.44, which the company reached on January 16th.The stock underperformed when compared to some of its competitors Monday, as Thermo Fisher Scientific Inc.  fell 0.47% to $585.51, Danaher Corp.  rose 0.09% to $202.63, and Becton Dickinson & Co.  fell 0.71% to $182.09.Trading volume  remained 138,976 below its 50-day average volume of 807,197.Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0878866978.SGD","BK4566","LU0289739343.SGD","LU0072461881.USD","STE","LU0070302665.USD","LU0128525929.USD","IE00B1BXHZ80.USD","LU1670628061.USD","BK4121","LU0432979614.USD","LU1720051017.SGD","LU0943347566.SGD","FMED","HRTS","LU0477156797.USD","LU1923622291.USD","BK4581","IE00BZ1G4Q59.USD","LU1064131342.USD","LU2023250504.SGD","LU1989771016.USD","LU2063271972.USD","LU1267930573.SGD","LU2211815571.USD","LU0345770993.USD","TMO","IHI","LU2764263039.SGD","TMED","LU1150488135.SGD","LU0124676726.USD","BK4533","LU0820561909.HKD","IE0034235188.USD","LU0006061336.USD","BDX","LU0208291251.USD","IE00BFXG1179.USD","SGXZ23171101.USD","LU1059921491.USD","LU0057025933.USD","LU2041044095.USD","LU0648000940.SGD","LU0109391861.USD","LU1291159041.SGD","LU0345770308.USD","GNMX","LU2106854487.HKD","DHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432656","title":"ADRs Close Higher; Argenx SE Climbs 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432656?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:31","pubTimestamp":1786998660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Monday, as the S&P/BNY Mellon index of American","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IBB","TBXU","IE0034235188.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0889565916.HKD","LU0320765992.SGD","IE0002141913.USD","LU1983260115.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","FMED","IE00BFTCPJ56.SGD","ARGX","BK4585","BK4139","LU2324357040.USD","BK4588","SCHY","LU0823416689.USD","BK4505","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660434081","title":"10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660434081","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660434081?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:09","pubTimestamp":1786997366,"startTime":"0","endTime":"0","summary":"10x Genomics director Sarah A. Teichmann disposes of USD 433,106 in common shares10x Genomics director Sarah A. Teichmann sold 7,551 Class A common shares on Aug. 13-14.Sales priced at $57.29 and $57.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9D8HHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","LU1861559042.SGD","FMED","TXG","LU1861558580.USD","BK4548","BK4585","BK4588","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660888434","title":"William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path","url":"https://stock-news.laohu8.com/highlight/detail?id=2660888434","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660888434?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:20","pubTimestamp":1786990827,"startTime":"0","endTime":"0","summary":"William Blair notes that Argenx (ARGX) announced top-line results from the Phase III ALKIVIA trial of Vyvgart in autoimmune myositis, showing a cli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","TBXU","LU2324357040.USD","LU0823416689.USD","IBB","IE00B4R5TH58.HKD","BK4505","ARGX","BK4139","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","LU1983260115.SGD","IE00BJJMRZ35.SGD","IE0034235188.USD","LU0109394709.USD","FMED","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431479","title":"Argenx Stock Heads for Record After Blockbuster Drug Delivers Another Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431479","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431479?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:04","pubTimestamp":1786989840,"startTime":"0","endTime":"0","summary":"Argenx's autoimmune drug Vyvgart achieved blockbuster status in just its second full year on the market. Now, the Dutch biotech is looking to expand use of the drug to treat more conditions.Argenx on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4139","IE00BFTCPJ56.SGD","IE0034235188.USD","IE0002141913.USD","LU0823416689.USD","FMED","TBXU","LU1983260115.SGD","BK4505","LU0889565916.HKD","LU0320765992.SGD","IBB","ARGX","IE00B2B36J28.USD","BK4585","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660650439","title":"argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660650439","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660650439?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:15","pubTimestamp":1786983324,"startTime":"0","endTime":"0","summary":"• Argenx announced positive Phase 3 ALKIVIA study results for VYVGART Hytrulo in myositis.\n• The company reported $4.15 billion in annual revenue and $1.29 billion in net profit.\n• Analysts issued Buy ratings with an average price target of $1083.77.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262112694-market-movers-argx-20260817","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","LU2324357040.USD","BK4588","IE0009355771.USD","IE00BJT1NW94.SGD","LU1983260115.SGD","BK4505","LU0823416689.USD","ARGX","LU0889565916.HKD","TBXU","BK4139","IE00BJJMRZ35.SGD","LU0109394709.USD","IBB","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0034235188.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439344","title":"Argenx Price Target Raised to $1215.00/Share from $1075.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439344","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660439344?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:07","pubTimestamp":1786982820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARGX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4139","IE00BFTCPJ56.SGD","IE0034235188.USD","IE0002141913.USD","LU0823416689.USD","FMED","TBXU","LU1983260115.SGD","BK4505","LU0889565916.HKD","LU0320765992.SGD","IBB","ARGX","IE00B2B36J28.USD","BK4585","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}